Your browser doesn't support javascript.
loading
Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort.
Miglioretti, Diana L; Abraham, Linn; Sprague, Brian L; Lee, Christoph I; Bissell, Michael C S; Ho, Thao-Quyen H; Bowles, Erin J A; Henderson, Louise M; Hubbard, Rebecca A; Tosteson, Anna N A; Kerlikowske, Karla.
Afiliação
  • Miglioretti DL; Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, School of Medicine, Davis, California, and Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington (D.L.M.).
  • Abraham L; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington (L.A., E.J.A.B.).
  • Sprague BL; Department of Surgery, Office of Health Promotion Research, Larner College of Medicine at the University of Vermont and University of Vermont Cancer Center, Burlington, Vermont (B.L.S.).
  • Lee CI; Department of Radiology, University of Washington School of Medicine; Department of Health Systems and Population Health, University of Washington School of Public Health; and Hutchinson Institute for Cancer Outcomes Research, Seattle, Washington (C.I.L.).
  • Bissell MCS; PicnicHealth, San Francisco, California (M.C.S.B.).
  • Ho TH; Department of Training and Scientific Research, University Medical Center, and Breast Imaging Unit, Diagnostic Imaging Center, Tam Anh General Hospital, Ho Chi Minh City, Vietnam (T.H.H.).
  • Bowles EJA; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington (L.A., E.J.A.B.).
  • Henderson LM; Department of Radiology, University of North Carolina, Chapel Hill, North Carolina (L.M.H.).
  • Hubbard RA; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (R.A.H.).
  • Tosteson ANA; The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth and Dartmouth Cancer Center, Lebanon, New Hampshire (A.N.A.T.).
  • Kerlikowske K; General Internal Medicine Section, Department of Veterans Affairs, and Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California (K.K.).
Ann Intern Med ; 2024 Sep 03.
Article em En | MEDLINE | ID: mdl-39222505
ABSTRACT

BACKGROUND:

False-positive results on screening mammography may affect women's willingness to return for future screening.

OBJECTIVE:

To evaluate the association between screening mammography results and the probability of subsequent screening.

DESIGN:

Cohort study.

SETTING:

177 facilities participating in the Breast Cancer Surveillance Consortium (BCSC). PATIENTS 3 529 825 screening mammograms (3 184 482 true negatives and 345 343 false positives) performed from 2005 to 2017 among 1 053 672 women aged 40 to 73 years without a breast cancer diagnosis. MEASUREMENTS Mammography results (true-negative result or false-positive recall with a recommendation for immediate additional imaging only, short-interval follow-up, or biopsy) from 1 or 2 screening mammograms. Absolute differences in the probability of returning for screening within 9 to 30 months of false-positive versus true-negative screening results were estimated, adjusting for race, ethnicity, age, time since last mammogram, BCSC registry, and clustering within women and facilities.

RESULTS:

Women were more likely to return after a true-negative result (76.9% [95% CI, 75.1% to 78.6%]) than after a false-positive recall for additional imaging only (adjusted absolute difference, -1.9 percentage points [CI, -3.1 to -0.7 percentage points]), short-interval follow-up (-15.9 percentage points [CI, -19.7 to -12.0 percentage points]), or biopsy (-10.0 percentage points [CI, -14.2 to -5.9 percentage points]). Asian and Hispanic/Latinx women had the largest decreases in the probability of returning after a false positive with a recommendation for short-interval follow-up (-20 to -25 percentage points) or biopsy (-13 to -14 percentage points) versus a true negative. Among women with 2 screening mammograms within 5 years, a false-positive result on the second was associated with a decreased probability of returning for a third regardless of the first screening result.

LIMITATION:

Women could receive care at non-BCSC facilities.

CONCLUSION:

Women were less likely to return to screening after false-positive mammography results, especially with recommendations for short-interval follow-up or biopsy, raising concerns about continued participation in routine screening among these women at increased breast cancer risk. PRIMARY FUNDING SOURCE National Cancer Institute.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Intern Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Intern Med Ano de publicação: 2024 Tipo de documento: Article